JP2006511196A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006511196A5 JP2006511196A5 JP2004509714A JP2004509714A JP2006511196A5 JP 2006511196 A5 JP2006511196 A5 JP 2006511196A5 JP 2004509714 A JP2004509714 A JP 2004509714A JP 2004509714 A JP2004509714 A JP 2004509714A JP 2006511196 A5 JP2006511196 A5 JP 2006511196A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- presenting cell
- antigen presenting
- mutation
- bound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 5
- 210000000612 antigen-presenting cell Anatomy 0.000 claims description 2
- 230000035772 mutation Effects 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10225144A DE10225144A1 (de) | 2002-05-29 | 2002-05-29 | An MHC-Moleküle bindende Tumor-assoziierte Peptide |
| PCT/EP2003/003181 WO2003102023A1 (de) | 2002-05-29 | 2003-03-27 | An mhc-moleküle bindende tumor-assoziierte peptide |
Related Child Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009283584A Division JP5042301B2 (ja) | 2002-05-29 | 2009-12-15 | Ｍｈｃ分子に結合する腫瘍関連ペプチド |
| JP2009283585A Division JP5042302B2 (ja) | 2002-05-29 | 2009-12-15 | Ｍｈｃ分子に結合する腫瘍関連ペプチド |
| JP2009283583A Division JP5042300B2 (ja) | 2002-05-29 | 2009-12-15 | Ｍｈｃ分子に結合する腫瘍関連ペプチド |
| JP2009283586A Division JP5042303B2 (ja) | 2002-05-29 | 2009-12-15 | Ｍｈｃ分子に結合する腫瘍関連ペプチド |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006511196A JP2006511196A (ja) | 2006-04-06 |
| JP2006511196A5 true JP2006511196A5 (enExample) | 2009-09-03 |
| JP4472520B2 JP4472520B2 (ja) | 2010-06-02 |
Family
ID=29557592
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004509714A Expired - Fee Related JP4472520B2 (ja) | 2002-05-29 | 2003-03-27 | Ｍｈｃ分子に結合する腫瘍関連ペプチド |
| JP2009283584A Expired - Fee Related JP5042301B2 (ja) | 2002-05-29 | 2009-12-15 | Ｍｈｃ分子に結合する腫瘍関連ペプチド |
| JP2009283586A Expired - Fee Related JP5042303B2 (ja) | 2002-05-29 | 2009-12-15 | Ｍｈｃ分子に結合する腫瘍関連ペプチド |
| JP2009283585A Expired - Fee Related JP5042302B2 (ja) | 2002-05-29 | 2009-12-15 | Ｍｈｃ分子に結合する腫瘍関連ペプチド |
| JP2009283583A Expired - Fee Related JP5042300B2 (ja) | 2002-05-29 | 2009-12-15 | Ｍｈｃ分子に結合する腫瘍関連ペプチド |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009283584A Expired - Fee Related JP5042301B2 (ja) | 2002-05-29 | 2009-12-15 | Ｍｈｃ分子に結合する腫瘍関連ペプチド |
| JP2009283586A Expired - Fee Related JP5042303B2 (ja) | 2002-05-29 | 2009-12-15 | Ｍｈｃ分子に結合する腫瘍関連ペプチド |
| JP2009283585A Expired - Fee Related JP5042302B2 (ja) | 2002-05-29 | 2009-12-15 | Ｍｈｃ分子に結合する腫瘍関連ペプチド |
| JP2009283583A Expired - Fee Related JP5042300B2 (ja) | 2002-05-29 | 2009-12-15 | Ｍｈｃ分子に結合する腫瘍関連ペプチド |
Country Status (15)
| Country | Link |
|---|---|
| US (5) | US7396904B2 (enExample) |
| EP (5) | EP1507795B1 (enExample) |
| JP (5) | JP4472520B2 (enExample) |
| AT (5) | ATE478088T1 (enExample) |
| AU (2) | AU2003224001B2 (enExample) |
| CA (5) | CA2736972C (enExample) |
| CY (5) | CY1108507T1 (enExample) |
| DE (6) | DE10225144A1 (enExample) |
| DK (5) | DK1734048T3 (enExample) |
| ES (5) | ES2317378T3 (enExample) |
| HR (1) | HRP20041108B1 (enExample) |
| PL (5) | PL210356B1 (enExample) |
| PT (5) | PT1734049E (enExample) |
| SI (5) | SI2006294T1 (enExample) |
| WO (1) | WO2003102023A1 (enExample) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7892559B2 (en) * | 2002-01-30 | 2011-02-22 | Survac Aps | Survivin-derived peptides and use thereof |
| US20050221350A1 (en) | 2002-05-29 | 2005-10-06 | Toni Weinschenk | Method for identifying immunoreactive peptides |
| DE10225139A1 (de) * | 2002-05-29 | 2004-02-26 | Immatics Biotechnologies Gmbh | Verfahren zur Identifizierung von immunreaktiven Peptiden |
| US7670604B2 (en) | 2002-12-13 | 2010-03-02 | Aurelium Biopharma, Inc. | Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease |
| ES2633389T3 (es) * | 2003-01-30 | 2017-09-21 | Survac Aps | Péptidos derivados de survivina y uso de los mismos |
| DE10313819A1 (de) * | 2003-03-24 | 2004-10-07 | Immatics Biotechnologies Gmbh | An MHC-Moleküle bindende Tumor-assoziierte Peptide |
| ATE458747T1 (de) * | 2003-12-01 | 2010-03-15 | Meiji Dairies Corp | Angiontensin converting enzyme hemmendes peptid |
| JP2007515924A (ja) * | 2003-12-15 | 2007-06-21 | アウレリウム バイオファーマ インク． | ビメンチン指向性診断法、および、多剤耐性を示す腫瘍性疾患の治療法 |
| DE102004011503A1 (de) * | 2004-01-28 | 2005-09-15 | Immatics Biotechnologies Gmbh | Verfahren zur Identifizierung und Quantifizierung von tumor-assoziierten Peptiden |
| DE102004026135A1 (de) * | 2004-05-25 | 2006-01-05 | Immatics Biotechnologies Gmbh | An MHC-Moleküle bindende Tumor-assoziierte Peptide |
| DE602004019215D1 (de) * | 2004-10-02 | 2009-03-12 | Immatics Biotechnologies Gmbh | Immunogene T-Helfer Epitope von menschlichen Tumorantigenen und deren Verwendung in immunotherapeutischen Methoden |
| IL172896A0 (en) * | 2005-12-29 | 2006-06-11 | Yeda Res & Dev | Cxcr4 inhibition |
| US20090004213A1 (en) * | 2007-03-26 | 2009-01-01 | Immatics Biotechnologies Gmbh | Combination therapy using active immunotherapy |
| CN105566450A (zh) * | 2007-07-27 | 2016-05-11 | 伊玛提克斯生物技术有限公司 | 免疫疗法的新型免疫抗原表位 |
| WO2009129498A2 (en) * | 2008-04-17 | 2009-10-22 | Immuneregen Biosciences, Inc. | Substance p and analogs thereof as a cancer immunogenic composition adjuvant |
| PT2119726E (pt) | 2008-05-14 | 2015-03-30 | Immatics Biotechnologies Gmbh | Novos e poderosos peptídeos para mhc classe ii derivados de survinina e neurocano |
| CN101451975B (zh) * | 2008-12-29 | 2012-01-25 | 浙江大学 | 一种检测胃癌预后与分期血清蛋白质的方法 |
| US8075895B2 (en) * | 2009-09-22 | 2011-12-13 | Janssen Pharmaceutica N.V. | Identification of antigenic peptides from multiple myeloma cells |
| GB201004575D0 (en) | 2010-03-19 | 2010-05-05 | Immatics Biotechnologies Gmbh | Composition of tumor associated peptides and related anti cancer vaccine for the treatment of gastric cancer and other cancers |
| GB201009222D0 (en) * | 2010-06-02 | 2010-07-21 | Immatics Biotechnologies Gmbh | Improved cancer therapy based on tumour associated antigens derived from cyclin D1 |
| WO2012048190A1 (en) | 2010-10-08 | 2012-04-12 | Regents Of The University Of Minnesota | Annexin ii compositions and methods |
| HRP20192262T1 (hr) | 2013-08-05 | 2020-03-06 | Immatics Biotechnologies Gmbh | Nova imunoterapija protiv nekoliko tumora, kao što su rak pluća, uključujući mikrocelularni karcinom pluća (nsclc) |
| JPWO2015050259A1 (ja) * | 2013-10-03 | 2017-03-09 | 大日本住友製薬株式会社 | 腫瘍抗原ペプチド |
| HUE060293T2 (hu) | 2013-11-13 | 2023-02-28 | Univ Minnesota | Annexin II variáns készítmények és eljárások |
| GB201505305D0 (en) | 2015-03-27 | 2015-05-13 | Immatics Biotechnologies Gmbh | Novel Peptides and combination of peptides for use in immunotherapy against various tumors |
| PT3388075T (pt) | 2015-03-27 | 2023-08-18 | Immatics Biotechnologies Gmbh | Novos péptidos e combinações de péptidos para uso em imunoterapia contra vários tumores |
| NL2014935B1 (en) | 2015-06-08 | 2017-02-03 | Applied Immune Tech Ltd | T cell receptor like antibodies having fine specificity. |
| MA42294B1 (fr) | 2015-07-01 | 2020-11-30 | Immatics Biotechnologies Gmbh | Nouveaux peptides et combinaison de peptides à utiliser en immunothérapie contre le cancer de l'ovaire et d'autres cancers |
| GB201511546D0 (en) | 2015-07-01 | 2015-08-12 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers |
| GB201520558D0 (en) * | 2015-11-23 | 2016-01-06 | Immunocore Ltd & Adaptimmune Ltd | Peptides |
| GB201520568D0 (en) | 2015-11-23 | 2016-01-06 | Immunocore Ltd | Peptides |
| GB201520550D0 (en) | 2015-11-23 | 2016-01-06 | Immunocore Ltd & Adaptimmune Ltd | Peptides |
| GB201521746D0 (en) | 2015-12-10 | 2016-01-27 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against CLL and other cancers |
| SG10202111399YA (en) | 2015-12-22 | 2021-11-29 | Immatics Biotechnologies Gmbh | Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers |
| DE102016005550B4 (de) | 2016-05-09 | 2024-09-26 | Hans-Georg Rammensee | Adjuvans zur lnduzierung einer zellulären lmmunantwort |
| GB201609193D0 (en) | 2016-05-25 | 2016-07-06 | Immatics Biotechnologies Gmbh | Novel peptides, combination of peptides as targets for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers |
| JP7075125B2 (ja) | 2016-05-25 | 2022-05-25 | イマティクス バイオテクノロジーズ ゲーエムベーハー | 標的としてのおよび胆嚢がんおよび胆管がんおよびその他のがんに対する免疫療法で使用するための新規ペプチド、ペプチド組み合わせ |
| EP4317432A3 (en) | 2016-12-08 | 2024-04-17 | Immatics Biotechnologies GmbH | T cell receptors with improved pairing |
| DE102016123893A1 (de) | 2016-12-08 | 2018-06-14 | Immatics Biotechnologies Gmbh | T-Zellrezeptoren mit verbesserter Bindung |
| WO2019160383A1 (ko) * | 2018-02-19 | 2019-08-22 | 고려대학교 산학협력단 | 열충격단백질의 에피토프를 포함하는 백신 및 이의 용도 |
| KR102184377B1 (ko) | 2018-02-19 | 2020-11-30 | 고려대학교 산학협력단 | 열충격단백질의 에피토프를 포함하는 백신 및 이의 용도 |
| BR102018010523A2 (pt) * | 2018-05-23 | 2020-04-28 | Univ Estadual Campinas Unicamp | peptídeo, composição farmacêutica compreendendo o mesmo e uso |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4810781A (en) * | 1987-01-15 | 1989-03-07 | The George Washington University | Methods of preparing epitopes of tumor associated antigens |
| US5739009A (en) * | 1996-12-12 | 1998-04-14 | Incyte Pharmaceuticals, Inc. | Adipocyte-specific differentiation-related protein |
| US6977074B2 (en) * | 1997-07-10 | 2005-12-20 | Mannkind Corporation | Method of inducing a CTL response |
| DE19837015C2 (de) * | 1998-08-14 | 2003-03-20 | Vasopharm Biotech Gmbh | Isolierte und gereinigte humane lösliche Guanylylcyclase alpha1/beta1 (hsGCalpha1/beta1) |
| US6809179B1 (en) | 1999-08-04 | 2004-10-26 | Boehringer Ingelheim International Gmbh | Tumor-associated antigen (R11) |
| DE19936563A1 (de) | 1999-08-04 | 2001-02-08 | Boehringer Ingelheim Int | Tumorassoziiertes Antigen |
| EP1259819A2 (en) * | 2000-02-24 | 2002-11-27 | Oxford GlycoSciences (UK) Limited | Diagnosis of bipolar affective disorder (bad) and unipolar depression |
| WO2002050103A2 (en) * | 2000-12-20 | 2002-06-27 | Glaxosmithkline Biologicals S.A. | Tumour-related antigens |
| US20030170719A1 (en) * | 2000-12-28 | 2003-09-11 | Akio Matsuda | NF-kappa B activating gene |
| AU2002309583A1 (en) * | 2001-04-18 | 2002-11-05 | Protein Desing Labs, Inc. | Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer |
| US6867283B2 (en) * | 2001-05-16 | 2005-03-15 | Technion Research & Development Foundation Ltd. | Peptides capable of binding to MHC molecules, cells presenting such peptides, and pharmaceutical compositions comprising such peptides and/or cells |
| WO2002101075A2 (en) * | 2001-06-13 | 2002-12-19 | Millennium Pharmaceuticals, Inc. | Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| AU2002346613A1 (en) * | 2001-12-03 | 2003-06-17 | Michael Bowen | Polynucleotides and polypeptides associated with the development of rheumatoid arthritis |
-
2002
- 2002-05-29 DE DE10225144A patent/DE10225144A1/de not_active Ceased
-
2003
- 2003-03-27 EP EP03720376A patent/EP1507795B1/de not_active Expired - Lifetime
- 2003-03-27 PT PT06015806T patent/PT1734049E/pt unknown
- 2003-03-27 CA CA2736972A patent/CA2736972C/en not_active Expired - Fee Related
- 2003-03-27 ES ES06015805T patent/ES2317378T3/es not_active Expired - Lifetime
- 2003-03-27 PL PL390816A patent/PL210356B1/pl unknown
- 2003-03-27 PT PT06015805T patent/PT1734048E/pt unknown
- 2003-03-27 AU AU2003224001A patent/AU2003224001B2/en not_active Ceased
- 2003-03-27 DK DK06015805T patent/DK1734048T3/da active
- 2003-03-27 DE DE50313004T patent/DE50313004D1/de not_active Expired - Lifetime
- 2003-03-27 PT PT08014305T patent/PT2014673E/pt unknown
- 2003-03-27 CA CA2736974A patent/CA2736974C/en not_active Expired - Fee Related
- 2003-03-27 SI SI200331885T patent/SI2006294T1/sl unknown
- 2003-03-27 WO PCT/EP2003/003181 patent/WO2003102023A1/de not_active Ceased
- 2003-03-27 DK DK08014305.0T patent/DK2014673T3/da active
- 2003-03-27 ES ES08014305T patent/ES2348468T3/es not_active Expired - Lifetime
- 2003-03-27 DE DE50310952T patent/DE50310952D1/de not_active Expired - Lifetime
- 2003-03-27 ES ES03720376T patent/ES2314196T3/es not_active Expired - Lifetime
- 2003-03-27 JP JP2004509714A patent/JP4472520B2/ja not_active Expired - Fee Related
- 2003-03-27 SI SI200331848T patent/SI2014673T1/sl unknown
- 2003-03-27 HR HRP20041108AA patent/HRP20041108B1/hr not_active IP Right Cessation
- 2003-03-27 CA CA2487137A patent/CA2487137C/en not_active Expired - Fee Related
- 2003-03-27 EP EP08014304A patent/EP2006294B1/de not_active Expired - Lifetime
- 2003-03-27 AT AT08014304T patent/ATE478088T1/de active
- 2003-03-27 ES ES06015806T patent/ES2317379T3/es not_active Expired - Lifetime
- 2003-03-27 PL PL390815A patent/PL211158B1/pl unknown
- 2003-03-27 SI SI200331451T patent/SI1734048T1/sl unknown
- 2003-03-27 PT PT03720376T patent/PT1507795E/pt unknown
- 2003-03-27 DE DE50312701T patent/DE50312701D1/de not_active Expired - Lifetime
- 2003-03-27 PL PL373700A patent/PL206306B1/pl unknown
- 2003-03-27 SI SI200331430T patent/SI1734049T1/sl unknown
- 2003-03-27 EP EP06015805A patent/EP1734048B1/de not_active Expired - Lifetime
- 2003-03-27 DK DK03720376T patent/DK1507795T3/da active
- 2003-03-27 PT PT08014304T patent/PT2006294E/pt unknown
- 2003-03-27 EP EP06015806A patent/EP1734049B1/de not_active Expired - Lifetime
- 2003-03-27 AT AT03720376T patent/ATE410442T1/de active
- 2003-03-27 CA CA2736921A patent/CA2736921C/en not_active Expired - Fee Related
- 2003-03-27 DE DE50310613T patent/DE50310613D1/de not_active Expired - Lifetime
- 2003-03-27 EP EP08014305A patent/EP2014673B1/de not_active Expired - Lifetime
- 2003-03-27 DE DE50310882T patent/DE50310882D1/de not_active Expired - Lifetime
- 2003-03-27 AT AT06015805T patent/ATE417859T1/de active
- 2003-03-27 PL PL390817A patent/PL211159B1/pl unknown
- 2003-03-27 PL PL390814A patent/PL211157B1/pl unknown
- 2003-03-27 DK DK08014304.3T patent/DK2006294T3/da active
- 2003-03-27 SI SI200331412T patent/SI1507795T1/sl unknown
- 2003-03-27 CA CA2736926A patent/CA2736926C/en not_active Expired - Fee Related
- 2003-03-27 AT AT06015806T patent/ATE416188T1/de active
- 2003-03-27 ES ES08014304T patent/ES2350461T3/es not_active Expired - Lifetime
- 2003-03-27 DK DK06015806T patent/DK1734049T3/da active
- 2003-03-27 AT AT08014305T patent/ATE466872T1/de active
-
2004
- 2004-11-29 US US10/999,364 patent/US7396904B2/en not_active Expired - Lifetime
-
2007
- 2007-08-30 US US11/848,110 patent/US7666984B2/en not_active Expired - Lifetime
- 2007-08-30 US US11/848,062 patent/US7763711B2/en not_active Expired - Lifetime
-
2008
- 2008-11-13 CY CY20081101297T patent/CY1108507T1/el unknown
- 2008-12-09 CY CY20081101425T patent/CY1108673T1/el unknown
- 2008-12-30 CY CY20081101508T patent/CY1108680T1/el unknown
-
2009
- 2009-12-15 JP JP2009283584A patent/JP5042301B2/ja not_active Expired - Fee Related
- 2009-12-15 JP JP2009283586A patent/JP5042303B2/ja not_active Expired - Fee Related
- 2009-12-15 JP JP2009283585A patent/JP5042302B2/ja not_active Expired - Fee Related
- 2009-12-15 JP JP2009283583A patent/JP5042300B2/ja not_active Expired - Fee Related
-
2010
- 2010-01-22 US US12/632,463 patent/US8399613B2/en not_active Expired - Fee Related
- 2010-01-22 US US12/632,541 patent/US8536304B2/en not_active Expired - Fee Related
- 2010-02-25 AU AU2010200689A patent/AU2010200689B2/en not_active Ceased
- 2010-07-30 CY CY20101100714T patent/CY1110723T1/el unknown
- 2010-11-03 CY CY20101100991T patent/CY1111174T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006511196A5 (enExample) | ||
| JP2004517472A5 (enExample) | ||
| EP2481422A3 (en) | Multiplex vaccines | |
| JP2004502858A5 (enExample) | ||
| EP2246067A3 (en) | Methods to elicit, enhance and sustain immune responses against MHC class I-restricted epitopes, for prophylactic or therapeutic purposes | |
| JPH101422A5 (enExample) | ||
| JP2007515393A5 (enExample) | ||
| JP2002334587A5 (enExample) | ||
| WO1999062923A3 (en) | Immunostimulatory oligonucleotides with modified bases and methods of use thereof | |
| EP1911461A3 (en) | HLA class I and II binding peptides and their uses | |
| JPH11302527A5 (enExample) | ||
| JP2005520490A5 (enExample) | ||
| ES2177927T3 (es) | Composicion para provocar una reaccion inmunologica a un determinante antigenico no proteinico. | |
| BR0010711A (pt) | Uso de moléculas co-estimulatórias solúveis para intensificar respostas imunes | |
| WO2003005880A3 (en) | Replikin peptides and uses thereof | |
| DE69515340D1 (de) | Impfstoff gegen mycobakterielle infektionen | |
| JP2004503217A5 (enExample) | ||
| JP2005154531A5 (enExample) | ||
| JP2006515744A5 (enExample) | ||
| AU2003224313A1 (en) | Mycobacterial antigens and uses thereof | |
| DE602004028266D1 (de) | Angiogene peptide und ihre verwendungen | |
| WO2003078595A3 (en) | Immunostimulatory double stranded rna and methods of inducing, enhancing or modulating the immune response | |
| JP2008546803A5 (enExample) | ||
| JP2002518346A5 (enExample) | ||
| JP2005515282A5 (enExample) |